InsiderTrades

Form 4 for CALX CALIX, INC

Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0001406666-24-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-12 2023-08-14 CALX Weening Michael Pres, CEO, Dir P - Purchase $34.98 +341 14.7K +2% +$11.9K
D 2024-02-12 2024-02-08 CALX Weening Michael Pres, CEO, Dir A - Grant $0.00 +54.5K 54.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-14 P A 341 $34.98 14,685 D — — (F1) The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 15, 2022 through August 14, 2023. This transaction is exempt under Rule 16b-3(c). (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 14, 2023, the last trading day of the purchase period.
2 Derivative Stock Option (right to buy) 2024-02-08 A A 54,500 $0.00 54,500 D $51.55 · 2024-02-08 to 2033-02-09 54,500 Common Stock (F3) On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 54,500 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.